Up 77% in a month! What's going on with the Mesoblast share price?
The gains that we've seen in the Mesoblast share price in recent weeks all stem from the blockbuster news that Mesoblast shared just before Christmas. As we covered back on 19 December, Mesoblast finally received the green light from the US Food and Drug Administration for its Ryoncil product. Ryoncil is a treatment for the deadly steroid-refractory acute graft versus host disease . It is the only therapy that has gained approval for use in children two months and older in the United States. Mesoblast has been preparing for this FDA decision throughout 2024. Optimism that the company would gain approval arguably fuelled much of the gains in the Mesoblast share price in the first half of the year. But the official green light really lit a rocket under the Mesoblast share price. On the day that this news became public, Mesoblast shares soared a whopping 54%. The company has continued to trend upwards ever since. So the Mesoblast share price is entering 2025 at a notable high. Let's se
